Also categorized in BoardNews:
Six Years Later, The Problem at HP is Still the Board
x hide permanently

Bill Ackman Likely to Face Trial on Allergan Insider-Trading Claims


Activist investor Bill Ackman and his estranged former collaborator in a 2014 hostile takeover bid for Botox-maker Allergan Inc. will likely face a jury trial next month over claims they engaged in insider trading. U.S. District Judge David Carter issued a tentative ruling at a hearing Friday, denying a request by Ackman and Valeant Pharmaceuticals International Inc. to throw out the allegations by Allergan shareholders...

Mentions: Management Takeover Bid hostile takeover